Stratos Wealth Advisors LLC Buys 28,022 Shares of Tilray Inc (NASDAQ:TLRY)

Stratos Wealth Advisors LLC grew its position in shares of Tilray Inc (NASDAQ:TLRY) by 253.5% during the third quarter, according to its most recent filing with the SEC. The firm owned 39,074 shares of the company’s stock after acquiring an additional 28,022 shares during the period. Stratos Wealth Advisors LLC’s holdings in Tilray were worth $69,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Madrona Financial Services LLC purchased a new stake in Tilray in the first quarter worth $124,000. SpiderRock Advisors LLC purchased a new stake in shares of Tilray in the 1st quarter worth about $247,000. Private Advisor Group LLC increased its stake in shares of Tilray by 7.3% in the 1st quarter. Private Advisor Group LLC now owns 175,845 shares of the company’s stock worth $434,000 after acquiring an additional 12,021 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in Tilray by 8.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock valued at $6,699,000 after acquiring an additional 213,834 shares during the period. Finally, Capstone Investment Advisors LLC boosted its stake in Tilray by 320.9% during the first quarter. Capstone Investment Advisors LLC now owns 95,736 shares of the company’s stock worth $236,000 after acquiring an additional 72,989 shares in the last quarter. Institutional investors own 9.35% of the company’s stock.

Tilray Stock Performance

Shares of Tilray stock opened at $1.68 on Thursday. Tilray Inc has a 1 year low of $1.45 and a 1 year high of $2.97. The firm’s 50-day moving average is $1.72 and its 200 day moving average is $1.80. The stock has a market cap of $1.52 billion, a price-to-earnings ratio of -6.22 and a beta of 2.13. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57.

Tilray (NASDAQ:TLRY) last issued its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.04). The firm had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business’s revenue was up 13.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.10) earnings per share. Sell-side analysts anticipate that Tilray Inc will post -0.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Roth Mkm lowered their target price on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a report on Friday, October 11th.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.